What we've been up to
Dutch “no cure, no pay” scheme launched
The Netherlands national health insurance council will only pay for new drugs if they produce a measurable effect on patients' health. If not, their cost will be reclaimed from the manufacturer. Novartis' asthma drug Xolair is the first to fall under the scheme Read More